- Home
- ATYR vs CTRN Comparison
ATYR vs CTRN Comparison
Compare ATYR & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- CTRN
- Stock Information
- Founded
- ATYR 2005
- CTRN 1946
- Country
- ATYR United States
- CTRN United States
- Employees
- ATYR N/A
- CTRN N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- CTRN Clothing/Shoe/Accessory Stores
- Sector
- ATYR Health Care
- CTRN Consumer Discretionary
- Exchange
- ATYR Nasdaq
- CTRN Nasdaq
- Market Cap
- ATYR 228.1M
- CTRN 219.8M
- IPO Year
- ATYR 2015
- CTRN 2005
- Fundamental
- Price
- ATYR $3.63
- CTRN $26.92
- Analyst Decision
- ATYR Strong Buy
- CTRN Strong Buy
- Analyst Count
- ATYR 5
- CTRN 3
- Target Price
- ATYR $19.25
- CTRN $27.67
- AVG Volume (30 Days)
- ATYR 960.8K
- CTRN 79.3K
- Earning Date
- ATYR 03-13-2025
- CTRN 03-18-2025
- Dividend Yield
- ATYR N/A
- CTRN N/A
- EPS Growth
- ATYR N/A
- CTRN N/A
- EPS
- ATYR N/A
- CTRN N/A
- Revenue
- ATYR $235,000.00
- CTRN $757,086,000.00
- Revenue This Year
- ATYR N/A
- CTRN $2.02
- Revenue Next Year
- ATYR $1,080.92
- CTRN $3.77
- P/E Ratio
- ATYR N/A
- CTRN N/A
- Revenue Growth
- ATYR N/A
- CTRN 2.00
- 52 Week Low
- ATYR $1.42
- CTRN $13.66
- 52 Week High
- ATYR $4.23
- CTRN $32.90
- Technical
- Relative Strength Index (RSI)
- ATYR 53.70
- CTRN 64.50
- Support Level
- ATYR $3.17
- CTRN $25.08
- Resistance Level
- ATYR $3.83
- CTRN $27.05
- Average True Range (ATR)
- ATYR 0.25
- CTRN 0.90
- MACD
- ATYR -0.02
- CTRN -0.15
- Stochastic Oscillator
- ATYR 43.60
- CTRN 93.40
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.